Acer Therapeutics Inc ACER:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:35 AM EST
3.20quote price arrow up+0.05 (+1.59%)
Volume
5,015
52 week range
1.08 - 5.84

...

Loading . . .

KEY STATS

  • Open3.23
  • Day High3.23
  • Day Low3.11
  • Prev Close3.15
  • 52 Week High5.84
  • 52 Week High Date08/07/20
  • 52 Week Low1.08
  • 52 Week Low Date03/23/20
  • Market Cap45.79M
  • Shares Out14.31M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • 1 Year % Change-3.96

RATIOS/PROFITABILITY

  • EPS (TTM)-2.07
  • P/E (TTM)-1.54
  • Fwd P/E (NTM)-1.97
  • EBITDA (MRQ)-21.75M
  • ROE (MRQ)-130.69%
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-1,609.48%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Acer Therapeutics Inc News

There is no recent news for this security.

Latest ACER News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The Company is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The Company is developing ACER-001, a...
Address
One Gateway Center (300 Washington St.)
Suite 351
Newton, MA
02458
United States